1. Home
  2. OBIO vs BGT Comparison

OBIO vs BGT Comparison

Compare OBIO & BGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.06

Market Cap

246.2M

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

HOLD

Current Price

$10.41

Market Cap

317.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBIO
BGT
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
246.2M
317.3M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
OBIO
BGT
Price
$4.06
$10.41
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$14.25
N/A
AVG Volume (30 Days)
228.8K
124.7K
Earning Date
03-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
33.13
N/A
EPS
N/A
N/A
Revenue
$33,482,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1169.22
N/A
52 Week Low
$2.20
$10.21
52 Week High
$5.42
$12.76

Technical Indicators

Market Signals
Indicator
OBIO
BGT
Relative Strength Index (RSI) 40.96 23.46
Support Level $4.02 N/A
Resistance Level $4.17 $10.85
Average True Range (ATR) 0.29 0.14
MACD -0.06 -0.01
Stochastic Oscillator 5.70 31.75

Price Performance

Historical Comparison
OBIO
BGT

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.

Share on Social Networks: